RBCL — RBC Life Sciences Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- -$2.09m
- $28.27m
Annual cashflow statement for RBC Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2010 December 31st | C2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 0.558 | -0.071 | -0.361 | -0.5 | -0.603 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.08 | 0.039 | -0.405 | 0.023 | 0.002 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.736 | -0.298 | 0.518 | 0.418 | -0.462 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | 0.545 | 0.125 | 0.445 | 0.294 | -0.608 |
| Capital Expenditures | -0.163 | -0.35 | -0.805 | -0.267 | -1.07 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.007 | 0.005 | 0.625 | 0 | — |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.156 | -0.345 | -0.18 | -0.267 | -1.07 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.111 | -0.169 | -0.182 | -0.215 | -0.212 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.248 | -0.362 | 0.038 | -0.15 | -1.82 |